Share & more
Rwanda has introduced three new AIDS therapy drugs, and halved the treatment price. The drugs - AZT, EPIVIR and CRIXIVAN - are taken in combination to help control opportunistic infections associated with AIDS. The triple therapy will cost US $580 per month per person through the National Centre for AIDS Control (PNLS) rather than the open market price of US $1,230, the Rwanda News Agency reported. The treatment will be available at Kigali’s main referral hospital, Kanombe military hospital and Butare university hospital. According to PNLS, 11 percent of Rwandans are HIV-positive.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions